Digital Gene Technologies

Digital Gene Technologies, Inc. was acquired by Neurome, Incorporated on October 8, 2004. Digital Gene Technologies, Inc. researches and develops treatments for cancer, diabetes, and central nervous system diseases using TOtal Gene Expression Analysis (TOGA) technology.